Resource
HERG - Recommendations for Trastuzumab (Herceptin®) for treatment of HER2-positive breast cancer
These guidelines provide guidance for clinicians about the use of Herceptin® in the treatment of both early and advanced disease.
| Filename | Unknown |
| Filesize | Link |
| Filetype | au/guidelines/trastuzumab/ (Mime Type: link) |
| Created On: | 01/04/2007 00:00 |
| Last updated on | 27/06/2011 08:34 |